Varian Installs Cyclotron at National Taiwan University Cancer Center
Installation marks milestone for first ProBeam system in Taiwan
Varian announced the installation of the cyclotron for its ProBeam® proton therapy system at the National Taiwan University Cancer Center (NTUCC). The cyclotron is a core piece of…
Varian and Yonsei Cancer Center, Yonsei University Health System Sign MOU to Further Innovation to Treat Cancer Patients
Varian announced that it has entered into a three-year agreement with Yonsei Cancer Center, Yonsei University Health System to collaborate on research and development projects in the field of radiation therapy and oncology.
Cancer is the leading…
Varian Partners with Sony Foundation Australia in the You Can Stay Program
Varian announced it has entered a partnership with Sony Foundation Australia to support its You Can Stay Program. The You Can Stay program provides free accommodations for cancer patients aged between 15 to 25 and their families in Australia who…
Expanded Intracranial Applications for HyperArc Therapy
Introduced in 2017 to help simplify SRS treatment planning and delivery for multiple brain metastases, HyperArc high-definition radiosurgery is now proving effective at treating benign intracranial lesions.
An Industry/Academic Partnership Yields Fruit: An Ultra-High Dose Rate Beam Monitoring Tool for FLASH Trials
Varian, in partnership with the Danish Centre for Particle Therapy (DCPT) at Aarhus University Hospital and the Cincinnati Children’s Hospital/UC Health Proton Therapy Center—two members of the FlashForward™ Consortium—has tested a specialized dose monito...